ARCHIVES

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

This article is from The Cancer Letter archive.

Vol. 32 No. 03 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

Bennett, Federal Prosecutors Reach $475,000 Settlement

October 31, 2014

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Henry Kaplan Was One Of The Century’s Top Scientists, DeVita Says

March 23, 1984

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Philadelphia Firm Wins CIDAC Award

August 24, 1984